Skip to main content
Top
Published in: Pediatric Radiology 11/2016

01-10-2016 | Original Article

Variants and pitfalls on radioiodine scans in pediatric patients with differentiated thyroid carcinoma

Authors: Mohamed Mostafa, Reza Vali, Jeffrey Chan, Yusuaf Omarkhail, Amer Shammas

Published in: Pediatric Radiology | Issue 11/2016

Login to get access

Abstract

Background

Potentially false-positive findings on radioiodine scans in children with differentiated thyroid carcinoma can mimic functioning thyroid tissue and functioning thyroid carcinomatous tissue. Such false-positive findings comprise variants and pitfalls that can vary slightly in children as compared with adults.

Objective

To determine the patterns and frequency of these potential false-positive findings on radioiodine scans in children with differentiated thyroid carcinoma.

Materials and methods

We reviewed a total of 223 radioiodine scans from 53 pediatric patients (mean age 13.3 years, 37 girls) with differentiated thyroid carcinoma. Focal or regional activity that likely did not represent functioning thyroid tissue or functioning thyroid carcinomatous tissue were categorized as variants or pitfalls. The final diagnosis was confirmed by reviewing the concurrent and follow-up clinical data, correlative ultrasonography, CT scanning, serum thyroglobulin and antithyroglobulin antibody levels. We calculated the frequency of these variants and pitfalls from diagnostic and post-therapy radioiodine scans.

Results

The most common variant on the radioiodine scans was the thymic activity (24/223, 10.8%) followed by the cardiac activity (8/223, 3.6%). Salivary contamination and star artifact, caused by prominent thyroid remnant, were the most important observed pitfalls.

Conclusion

Variants and pitfalls that mimic functioning thyroid tissue or functioning thyroid carcinomatous tissue on radioiodine scan in children with differentiated thyroid carcinoma are not infrequent, but they decrease in frequency on successive radioiodine scans. Potential false-positive findings can be minimized with proper knowledge of the common variants and pitfalls in children and correlation with clinical, laboratory and imaging data.
Literature
1.
go back to reference Shapiro B, Rufini V, Jarwan A et al (2000) Artifacts, anatomical, and physiological variants, and unrelated diseases that might cause false-positive whole-body 131-I scans in patients with thyroid cancer. Semin Nucl Med 30:115–132CrossRefPubMed Shapiro B, Rufini V, Jarwan A et al (2000) Artifacts, anatomical, and physiological variants, and unrelated diseases that might cause false-positive whole-body 131-I scans in patients with thyroid cancer. Semin Nucl Med 30:115–132CrossRefPubMed
2.
go back to reference Intenzo CM, Jabbour S, Dam HQ et al (2005) Changing concepts in the management of differentiated thyroid cancer. Semin Nucl Med 35:257–265CrossRefPubMed Intenzo CM, Jabbour S, Dam HQ et al (2005) Changing concepts in the management of differentiated thyroid cancer. Semin Nucl Med 35:257–265CrossRefPubMed
3.
go back to reference Glazer DI, Brown RKJ, Wong KK et al (2013) SPECT/CT evaluation of unusual physiologic radioiodine biodistributions: pearls and pitfalls in image interpretations. Radiographics 33:397–418CrossRefPubMed Glazer DI, Brown RKJ, Wong KK et al (2013) SPECT/CT evaluation of unusual physiologic radioiodine biodistributions: pearls and pitfalls in image interpretations. Radiographics 33:397–418CrossRefPubMed
4.
go back to reference Buton L, Morel O, Gault P et al (2013) False-positive iodine-131 whole-body scan findings in patients with differentiated thyroid carcinoma: report of 11 cases and review of literature. Ann Endocrinol 74:221–230CrossRef Buton L, Morel O, Gault P et al (2013) False-positive iodine-131 whole-body scan findings in patients with differentiated thyroid carcinoma: report of 11 cases and review of literature. Ann Endocrinol 74:221–230CrossRef
5.
go back to reference Choi HS, Kim SH, Park SY et al (2014) Clinical significance of diffuse intrathoracic uptake on post-therapy I-131 scans in thyroid cancer patients. Nucl Med Mol Imaging 48:63–71CrossRefPubMed Choi HS, Kim SH, Park SY et al (2014) Clinical significance of diffuse intrathoracic uptake on post-therapy I-131 scans in thyroid cancer patients. Nucl Med Mol Imaging 48:63–71CrossRefPubMed
6.
go back to reference Ozguven M, Ilgan S, Arslan N et al (2004) Unusual patterns of I-131 contamination. Ann Nucl Med 18:271–274CrossRefPubMed Ozguven M, Ilgan S, Arslan N et al (2004) Unusual patterns of I-131 contamination. Ann Nucl Med 18:271–274CrossRefPubMed
7.
go back to reference Omur O, Akgun A, Ozcan Z et al (2009) Clinical implications of diffuse hepatic uptake observed in postablative and post therapeutic I-131 scans. Clin Nucl Med 34:11–14CrossRefPubMed Omur O, Akgun A, Ozcan Z et al (2009) Clinical implications of diffuse hepatic uptake observed in postablative and post therapeutic I-131 scans. Clin Nucl Med 34:11–14CrossRefPubMed
9.
go back to reference Blum M, Tiu S, Chu M et al (2011) I-131 SPECT/CT elucidates cryptic findings on planar whole-body scans and can reduce needless therapy with I-131 in post-thyroidectomy thyroid cancer patients. Thyroid 21:1035–1048CrossRef Blum M, Tiu S, Chu M et al (2011) I-131 SPECT/CT elucidates cryptic findings on planar whole-body scans and can reduce needless therapy with I-131 in post-thyroidectomy thyroid cancer patients. Thyroid 21:1035–1048CrossRef
10.
go back to reference Francis GL, Waguespack SG, Bauer AJ et al (2015) Management guidelines for children with thyroid nodules and differentiated thyroid cancer. The American Thyroid Association Guidelines Task Force on Pediatric Thyroid Cancer. Thyroid 25:716–759CrossRefPubMedPubMedCentral Francis GL, Waguespack SG, Bauer AJ et al (2015) Management guidelines for children with thyroid nodules and differentiated thyroid cancer. The American Thyroid Association Guidelines Task Force on Pediatric Thyroid Cancer. Thyroid 25:716–759CrossRefPubMedPubMedCentral
12.
go back to reference Brenner DJ, Elliston CD, Hall EJ et al (2001) Estimated risk of radiation-induced fatal cancer from pediatric CT. AJR Am J Roentgenol 176:289–296CrossRefPubMed Brenner DJ, Elliston CD, Hall EJ et al (2001) Estimated risk of radiation-induced fatal cancer from pediatric CT. AJR Am J Roentgenol 176:289–296CrossRefPubMed
13.
go back to reference Van Nostrand D, Aiken M, Atkins F et al (2009) The utility of radioiodine scans prior to iodine 131 ablation in patients with well-differentiated thyroid cancer. Thyroid 19:849–855CrossRefPubMed Van Nostrand D, Aiken M, Atkins F et al (2009) The utility of radioiodine scans prior to iodine 131 ablation in patients with well-differentiated thyroid cancer. Thyroid 19:849–855CrossRefPubMed
14.
go back to reference Byeong-Cheol A (2011) Physiologic and false positive pathologic uptakes on radioiodine whole body scan. In: Gholamrezanezhad A (ed) 12 chapters on nuclear medicine. In Tech, Rijeka, pp 1–25 Byeong-Cheol A (2011) Physiologic and false positive pathologic uptakes on radioiodine whole body scan. In: Gholamrezanezhad A (ed) 12 chapters on nuclear medicine. In Tech, Rijeka, pp 1–25
15.
go back to reference Chung JK (2002) Sodium iodide symporter: its role in nuclear medicine. J Nucl Med 43:1188–1200PubMed Chung JK (2002) Sodium iodide symporter: its role in nuclear medicine. J Nucl Med 43:1188–1200PubMed
16.
go back to reference Oh J-R, Ahn B-C (2012) False-positive uptake on radioiodine whole-body scintigraphy: physiologic and pathologic variants unrelated to thyroid cancer. Am J Nucl Med Mol Imaging 2:362–385PubMedPubMedCentral Oh J-R, Ahn B-C (2012) False-positive uptake on radioiodine whole-body scintigraphy: physiologic and pathologic variants unrelated to thyroid cancer. Am J Nucl Med Mol Imaging 2:362–385PubMedPubMedCentral
17.
go back to reference Michigishi T, Mizukami Y, Shuke NK et al (1993) Visualization of the thymus with therapeutic doses of radioiodine in patients with thyroid cancer. Eur J Nucl Med 20:75–79CrossRefPubMed Michigishi T, Mizukami Y, Shuke NK et al (1993) Visualization of the thymus with therapeutic doses of radioiodine in patients with thyroid cancer. Eur J Nucl Med 20:75–79CrossRefPubMed
18.
go back to reference Vermiglio F, Baudin E, Travagli JP et al (1996) Iodine concentration by the thymus in thyroid carcinoma. J Nucl Med 37:1830–1831PubMed Vermiglio F, Baudin E, Travagli JP et al (1996) Iodine concentration by the thymus in thyroid carcinoma. J Nucl Med 37:1830–1831PubMed
19.
go back to reference Wilson LM, Barrington SF, Morrison ID et al (1998) Therapeutic implications of thymic uptake of radioiodine in thyroid carcinoma. Eur J Nucl Med 25:622–628CrossRefPubMed Wilson LM, Barrington SF, Morrison ID et al (1998) Therapeutic implications of thymic uptake of radioiodine in thyroid carcinoma. Eur J Nucl Med 25:622–628CrossRefPubMed
20.
go back to reference Mello ME, Flamini RC, Corbo R et al (2009) Radioiodine concentration by the thymus in differentiated thyroid carcinoma: report of five cases. Arq Bras Endocrinol Metabol 53:874–879CrossRefPubMed Mello ME, Flamini RC, Corbo R et al (2009) Radioiodine concentration by the thymus in differentiated thyroid carcinoma: report of five cases. Arq Bras Endocrinol Metabol 53:874–879CrossRefPubMed
21.
go back to reference Davidson J, McDougall IR (2000) How frequently is the thymus seen on whole-body iodine-131 diagnostic and post-treatment scans? Eur J Nucl Med 27:425–430CrossRefPubMed Davidson J, McDougall IR (2000) How frequently is the thymus seen on whole-body iodine-131 diagnostic and post-treatment scans? Eur J Nucl Med 27:425–430CrossRefPubMed
22.
23.
go back to reference Meller J, Becker W (2000) The human sodium iodine symporter (NIS) as a key for specific thymic iodine-131 uptake. Eur J Nucl Med 27:473–474CrossRefPubMed Meller J, Becker W (2000) The human sodium iodine symporter (NIS) as a key for specific thymic iodine-131 uptake. Eur J Nucl Med 27:473–474CrossRefPubMed
24.
go back to reference Connolly LP, Connolly SA (2003) Thymic uptake of radiopharmaceuticals. Clin Nucl Med 28:648–651PubMed Connolly LP, Connolly SA (2003) Thymic uptake of radiopharmaceuticals. Clin Nucl Med 28:648–651PubMed
25.
go back to reference Riesco-Eizaguirre G, Santisteban P (2006) A perspective view of sodium iodide symporter research and its clinical implications. Eur J Endocrinol 155:495–512CrossRefPubMed Riesco-Eizaguirre G, Santisteban P (2006) A perspective view of sodium iodide symporter research and its clinical implications. Eur J Endocrinol 155:495–512CrossRefPubMed
26.
go back to reference Aktas A, Kocabas B, Erhamamcı S et al (2015) Cardiac blood pool activity on postablation radioiodine imaging. Ann Nucl Med 29:170–176CrossRefPubMed Aktas A, Kocabas B, Erhamamcı S et al (2015) Cardiac blood pool activity on postablation radioiodine imaging. Ann Nucl Med 29:170–176CrossRefPubMed
27.
go back to reference Jong I, Taubman K, Schlicht S (2005) Bronchiectasis simulating pulmonary metastases on iodine-131 scintigraphy in well-differentiated thyroid carcinoma. Clin Nucl Med 30:688–689CrossRefPubMed Jong I, Taubman K, Schlicht S (2005) Bronchiectasis simulating pulmonary metastases on iodine-131 scintigraphy in well-differentiated thyroid carcinoma. Clin Nucl Med 30:688–689CrossRefPubMed
28.
go back to reference Tsai D-H, Hsiao H-C, Tu S-T et al (2007) Concomitant false-positive and false-negative iodine-131 scintigraphy secondary to bronchiectasis and cervical lymph node metastasis in a patient with thyroid cancer: the usefulness of FDG-PET/CT. Ann Nucl Med Sci 20:217–221 Tsai D-H, Hsiao H-C, Tu S-T et al (2007) Concomitant false-positive and false-negative iodine-131 scintigraphy secondary to bronchiectasis and cervical lymph node metastasis in a patient with thyroid cancer: the usefulness of FDG-PET/CT. Ann Nucl Med Sci 20:217–221
29.
go back to reference Klebanoff SJ, Hamon CB (1972) Role of myeloperoxidase-mediated antimicrobial systems in intact leukocytes. J Reticuloendothel Soc 12:170–196PubMed Klebanoff SJ, Hamon CB (1972) Role of myeloperoxidase-mediated antimicrobial systems in intact leukocytes. J Reticuloendothel Soc 12:170–196PubMed
30.
go back to reference Regalbuto C, Buscema M, Arena S et al (2002) False-positive findings on (131)I whole-body scans because of posttraumatic superficial scabs. J Nucl Med 43:207–209PubMed Regalbuto C, Buscema M, Arena S et al (2002) False-positive findings on (131)I whole-body scans because of posttraumatic superficial scabs. J Nucl Med 43:207–209PubMed
31.
go back to reference Brucker-Davis F, Reynolds JC, Skarulis MC et al (1996) False-positive iodine-131 whole-body scans due to cholecystitis and sebaceous cyst. J Nucl Med 37:1690–1693PubMed Brucker-Davis F, Reynolds JC, Skarulis MC et al (1996) False-positive iodine-131 whole-body scans due to cholecystitis and sebaceous cyst. J Nucl Med 37:1690–1693PubMed
32.
go back to reference Wartofsky L, Van Nostrand D (2006) Thyroid cancer: a comprehensive guide to clinical management, 2nd edn. Humana Press, TotowaCrossRef Wartofsky L, Van Nostrand D (2006) Thyroid cancer: a comprehensive guide to clinical management, 2nd edn. Humana Press, TotowaCrossRef
33.
go back to reference Raza H, Khan AU, Hameed A et al (2006) Quantitative evaluation of salivary gland dysfunction after radioiodine therapy using salivary gland scintigraphy. Nucl Med Commun 27:495–499CrossRefPubMed Raza H, Khan AU, Hameed A et al (2006) Quantitative evaluation of salivary gland dysfunction after radioiodine therapy using salivary gland scintigraphy. Nucl Med Commun 27:495–499CrossRefPubMed
Metadata
Title
Variants and pitfalls on radioiodine scans in pediatric patients with differentiated thyroid carcinoma
Authors
Mohamed Mostafa
Reza Vali
Jeffrey Chan
Yusuaf Omarkhail
Amer Shammas
Publication date
01-10-2016
Publisher
Springer Berlin Heidelberg
Published in
Pediatric Radiology / Issue 11/2016
Print ISSN: 0301-0449
Electronic ISSN: 1432-1998
DOI
https://doi.org/10.1007/s00247-016-3655-2

Other articles of this Issue 11/2016

Pediatric Radiology 11/2016 Go to the issue